Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Youth dialogue on mental health and well-being in education
UNESCO
2 - 2.10 PM: Opening & welcome Kabi Paudel and Nour Aldulaimy, SDG 4 Youth & Student Network Poem on mental health by Yande Chionita Banda 2.10 - 2.20 PM : Framing Definitions and key concepts on Mental Health and Psychosocial Support Yongfeng...
Lancia Gallery Launches in Los Angeles, Celebrating Italian Automotive Design Through Fine-Art Photography
EIN Presswire
Created by Gordon Fraser and photographer Walter Fulbright, Lancia Gallery explores Italian automotive design through the architecture of Los Angeles.
Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight
GlobeNewswire, Inc.
New York, USA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight The type 2 diabetes...
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
GlobeNewswire, Inc.
Data demonstrated scalable production, in vivo function and immune evasion, and updated progress toward clinical dosing of CNTY-813, Century's iPSC-derived islet replacement therapy for type 1 diabetes CNTY-813 IND submission remains on track for...
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
GlobeNewswire, Inc.
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy – BRISBANE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative,...
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
GlobeNewswire, Inc.
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2...
Gias Foods, Inc. Recalls bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
GlobeNewswire, Inc.
NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Gias Foods of New York, NY is recalling all lot codes of bettergoods Authentic Italian Lemon Alfredo Fettuccine, because it has the potential to be contaminated with Listeria monocytogenes, an organism...
Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress
GlobeNewswire, Inc.
New data suggest that givinostat treatment may slow the decline of upper limb function in boys with Duchenne muscular dystrophy compared with modelled external comparator disease trajectories derived from a single centre natural history study...
Influential Women Features Vita Oyler: Champions Resilience Through Chronic Pain Rehabilitation And Holistic Wellness
EIN Presswire
CALIFORNIA, CA, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- A Lifelong Commitment To Helping Others Find Practical Paths Forward California – With more than 35 years of experience in rehabilitation counseling, Vita Oyler has...
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR. A conference call will be held on September 30, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Strong momentum and expanding global access position AGAMREE® for...
The Surgeon Show 2027 Returns with Intuitive as Headline Partner
EIN Presswire
The Surgeon Show 2027 Returns with Intuitive as Headline Partner LONDON, UNITED KINGDOM, October 5, 2026 /EINPresswire.com/ -- Registration is now open for The Surgeon Show 2027, with Intuitive announced as headline partner for the leading...
Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight The software as a medical device market is experiencing strong growth, driven by the...
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
GlobeNewswire, Inc.
- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate changes in blood-based biomarkers associated with...
VCD Medical Receives U.S. FDA 510(k) Clearance for VEnice™ Vein Closure Device
GlobeNewswire, Inc.
Brescia, Italy, Sept. 29, 2026 (GLOBE NEWSWIRE) -- VCD Medical, an Italy-based company developing novel, minimally invasive vein closure technologies, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its VEnice™ Vein...
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
GlobeNewswire, Inc.
ROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress...
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
GlobeNewswire, Inc.
Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed led by 4BIO Capital with follow-on participation from the company's original pre-seed investor EXTEND (CDP Venture Capital SGR, Angelini Ventures and...
APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES
GlobeNewswire, Inc.
Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed is led by 4BIO Capital with follow-on participation from the company's original pre-seed investor EXTEND (CDP Venture Capital SGR, Angelini Ventures...
Acne Vulgaris Market Set for Significant Growth During the Forecast Period (2026–2036), Amid Rising Disease Burden and Therapeutic Advances | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Acne Vulgaris Market Set for Significant Growth During the Forecast Period (2026–2036), Amid Rising Disease Burden and Therapeutic Advances | DelveInsight The acne vulgaris market is expected to...
Live Whole Health #336: Spaghetti squash is your fall must-try
U.S. Department of Veterans Affairs
Autumn harvest: Rediscovering spaghetti squash As the air turns crisp and leaves begin to fall, I find myself drawn to local farms and markets in search of seasonal treasures—apples, pumpkins and spaghetti squash.
Alex Bodi and Prof. Dr Dieter Lazik sign a contract for ALPHA WHEY and BODI Energy Drink
GlobeNewswire, Inc.
Hamburg, Germany, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Alex Bodi is relying on scientific collaboration and international partnerships to build up ALPHA WHEY and BODI Energy Drink.
Sign up for:
Health Watch Italy
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.